Understanding pulmonary hypertension knowledge questionnaire
Part of Heart & circulation, Lungs & breathing clinical trials.
This study aims to validate a questionnaire that measures how well patients understand pulmonary hypertension. If you have been diagnosed with Group 1 Pulmonary Arterial Hypertension (PAH) and can read the questionnaire, you may be able to help researchers make sure it's a useful tool.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with Group 1 Pulmonary Arterial Hypertension (PAH)
- Able to read and understand the language of the questionnaire
- Willing to provide consent to participate
- No serious vision, hearing, or thinking problems that could make it hard to fill out the questionnaire
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how patients with pulmonary hypertension and their caregivers get information about the condition. By filling out a questionnaire, you can help improve how health information is shared in the future.
This study looks at the timing between first symptoms and diagnosis of pulmonary arterial hypertension (PAH). It aims to better understand how quickly patients get diagnosed after symptoms appear.
This study is developing and testing a new survey to measure how pulmonary arterial hypertension affects daily life and well-being in Chinese patients. Your feedback helps create a tool that better captures what matters most to people living with this condition.
This study looks at how things in your environment (like pollution, diet, or lifestyle) might be linked to pulmonary hypertension. By comparing two groups of patients, researchers hope to find new clues about the condition.
This study looks at the experiences of people living with pulmonary hypertension. It may help improve how this condition is managed and how studies like this are run.
This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.
Hear when a new Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.